Michael R. Stratton

2 ta ish

Wellcome Sanger Institute

1. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

   Kornelius Schulze, Sandrine Imbeaud, Éric Letouzé +21

   MaqolaOAOchiq kirish20152 iqtibos

   ABIABI:AkademIndex/2026.other.247239

2. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

   Wanjuan Yang, Jorge Soares, Patricia Greninger +14

   Maqola20122 iqtibos

   ABIABI:AkademIndex/2026.other.782592